|Assessment process complete
|For the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy.
|Rapid review commissioned
|Rapid review completed
|Rapid review outcome
|Full Pharmacoeconomic Evaluation not recommended at the submitted price.
The HSE has approved reimbursement following confidential price negotiations: April 2018